ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,791, issued on April 14, was assigned to EXCELMAB INC. (Guangzhou, China).
"Bispecific antibody, preparation method therefor and application thereof" was invented by Wenjun Zhang (Guangzhou, China), Feng Li (Guangzhou, China), Yanan Hua (Guangzhou, China), Jiaxi Liu (Guangzhou, China) and Chunhua Fang (Guangzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a bispecific antibody and a preparation method therefor. The antibody comprises structural domains capable of binding to CD20 and CD3, and a heterodimer Fc region. The structural domains capable of binding to CD20 and CD3 are each independently selected from a Fab region, a ...